Get started
Author

Jean Vandebroek

Observed names: J VANDEBROEK, J Vandebroek, J. Vandebroek, J.E. Vandebroek
OpenAlex ID: A5000802010
Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
2017 · Bram De Laere, Pieter-Jan van Dam, et al. · European Urology · 141
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin–vindesine
2001 · J.F. Vansteenkiste, J.E. Vandebroek, et al. · Annals of Oncology · 102
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine
2003 · Johan Vansteenkiste, Jean Vandebroek, et al. · Lung Cancer · 51
Circulating tumor cells and survival in abiraterone‐ and enzalutamide‐treated patients with castration‐resistant prostate cancer
2018 · Bram De Laere, Steffi Oeyen, et al. · The Prostate · 26
PDF
A Phase II Study of the Combination of Endocrine Treatment and Bortezomib in Patients with Endocrine Resistant Metastatic Breast Cancer.
2009 · X. Trinh, S. Van Laere, et al. · Cancer Research · 17
The place of death of cancer patients in Antwerp
1998 · D Schrijvers, E Joosens, et al. · Palliative Medicine · 14
Phase I trial of erbulozole (R55104).
1994 · S J Van Belle, W Distelmans, et al. · PubMed · 10
Gemcitabine monotherapy (GEM) versus cisplatin-based chemotherapy in symptomatic advanced NSCLC: A prospective randomised comparison of symptom control
2000 · J Vansteenkiste, J Vandebroek, et al. · Lung Cancer · 8
Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU.
1996 · M De Brabander, J Vandebroek, et al. · PubMed · 8
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial
1995 · J. Vansteenkiste, J. Vandebroek, et al. · Lung Cancer · 8
Levamisole in the treatment of cancer: anything new? (Review).
1992 · M De Brabander, J De Crée, et al. · PubMed · 7
Circulating tumour cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
2017 · Bram De Laere, Peter Van Oyen, et al. · Journal of Clinical Oncology · 4
Vorozole-racemate (R 76713): A specific non-steroidal aromatase inhibitor. Pilot study advanced postmenopausal breast cancer
1993 · M. Borms, J. Vandebroek, et al. · European Journal of Cancer · 3
The Effects of Short-term Treatment With Levamisole on Cytokines in Volunteers and Cancer-patients
1992 · M DEBRABANDER, V ROELS, et al. · International Journal of Oncology · 2
Prevalence and heterogeneity of androgen receptor splice variants and intra-AR structural variation in patient with castration-resistant prostate cancer.
2017 · Luc Yves Dirix, Bram De Laere, et al. · Journal of Clinical Oncology
Patterns of canonical and non-canonical TGFβ signaling in inflammatory breast cancer cells on cancer cell motility.
2016 · Charlotte Rypens, Melike Marsan, et al. · Journal of Clinical Oncology
Weekly paclitaxel versus weekly docetaxel in elderly and frail patients with metastatic breast carcinoma having failed previous anthracyclines: a randomised phase II study of the Belgian Society of Medical Oncology.
2009 · B Beuselinck, W Wynendaele, et al. · Cancer Research
Toxiticy data of a randomised Phase II study comparing weekly paclitaxel versus weekly docetaxel in elderly and frail patients with metastatic breast cancer
2008 · B. Beuselinck, H. Wildiers, et al. · Critical Reviews in Oncology/Hematology
Symptom control and clinical benefit in advanced non-small cell lung cancer: Early report of a randomized study of gemclcitabine monotherapy versus cisplatinum-vindesine
1997 · J. Vansteenkiste, J. Vandebroek, et al. · European Journal of Cancer
201 Preliminary report of a randomized study of gemcitabine monotherapy versus cisplatinum-vindesine in advanced non-small cell lung cancer
1997 · J. Vansteenkiste, J. Vandebroek, et al. · Lung Cancer
1110 Vindesine-Ifosfamide-Platinum (VIP) chemotherapy in patients with inoperable stage III and IV non small cell lung cancer. A phase II trial
1995 · J. Vansteenkiste, J. Vandebroek, et al. · European Journal of Cancer
Vindesine-ifosfamide-platinum (VIP) chemotherapy in patients with stage III and IV non small cell lung cancer. A phase II trial
1994 · J. Vansteenkiste, J. Vandebroek, et al. · Lung Cancer
Works count: 22
Citation count: 401
H-index: 8
I10-index: 7
Year
Topic
Type